Outcomes of Selective Retina Therapy for Central Serous Chorioretinopathy


SCIENTIFIC POSTER

Outcomes of Selective Retina Therapy for Central Serous Chorioretinopathy by Joo Yeon Kim, South Korea


ABSTRACT

Purpose:

To determine the effect of Selective retina therapy (SRT) on patients with central serous chorioretinopathy (CSC).

Method:

We collected demographic and ophthalmic data from patients of CSC who were treated with SRT retrospectively. The best corrected visual acuity (BCVA) and optical coherence tomography (OCT) at baseline and follow-up visits were compared longitudinally.

Results:

Seventeen eyes of 16 patients were recruited. The mean age was 53.43(37~71 years). Initial mean BCVA was 0.20(logMAR) and final mean BCVA was 0.12 (logMAR) which demonstrated visual acuity improvement of 0.08 (logMAR). Subretinal fluid resolved partially or completely in 14 eyes of 16 eyes (87.5%). Central retinal thickness (CRT) decreased from 327±59㎛ to 151±15㎛. The amount of decrease in CRT after SRT was 174.78㎛. 4 eyes required addtional SRT. No patients after complete remission manifested recurr of CSC. During the follow up period, no adverse effect was observed.

Conclusion:

SRT with CSC patients was effective and showed no complications.


CONTACT DETAILS

JooYeon Kim
Seoul, South Korea
Email : redmanson@kimeye.com
Cell Phone: +821037777841
Work Phone: +82226397777